Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryodoraku and HRV Changes After PPI in GERD
NCT02149914Unknown
- Sponsor
- Taichung Tzu Chi Hospital
- Start
- May 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by Taichung Tzu Chi Hospital. Primary endpoint: Gastroesophageal reflux disease questionnaire at 4 weeks. Status: unknown.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02149914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149914.